Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 1;17(6):e0268230.
doi: 10.1371/journal.pone.0268230. eCollection 2022.

COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans

John K Ahiakpa  1   2 , Nanma T Cosmas  3 , Felix E Anyiam  4 , Kingsley O Enalume  5 , Ibrahim Lawan  6 , Ijuptil B Gabriel  7 , Chinonyelum L Oforka  8 , Hamze G Dahir  9 , Salisu T Fausat  10 , Maureen A Nwobodo  11 , Getrude P Massawe  12 , Adachukwu S Obagha  13 , Debra U Okeh  14 , Benjamin Karikari  2   15 , Samuel T Aderonke  16 , Olushola M Awoyemi  17 , Idowu A Aneyo  8 , Funmilayo V Doherty  18
Affiliations

COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans

John K Ahiakpa et al. PLoS One. .

Abstract

Introduction: The willingness of Africa's population to patronise the COVID-19 vaccines is critical to the efficiency of national immunisation programmes. This study surveys the views of adult African inhabitants toward vaccination and the possibility of participating or not participating in governments' efforts to get citizens vaccinated.

Method: A cross-sectional online survey of adult Africans was undertaken from December 2020 to March 2021. Responses were anonymised. The Pearson Chi-square test was performed to determine whether or not there were any variations in knowledge, awareness, perception and acceptance of the COVID-19 vaccines among the participants. Binomial logistic regression was used to evaluate the factors associated with willingness to accept the COVID-19 vaccines and participate in immunisation programmes.

Results: The results indicate that COVID-19 vaccines are more likely to be used by adult Africans over the age of 18 who are largely technologically savvy (55 percent) if the vaccine is made broadly available. A total of 33 percent of those who responded said they were unlikely to receive the vaccine, with another 15 percent stating they were undecided. Aside from that, we found that vaccine hesitancy was closely associated with socio-demographic characteristics such as age, gender, education and source of information. We also found that there were widespread conspiracies and myths about the COVID-19 vaccines.

Conclusion: More than one-third of African adults who participated in the survey indicated they would not receive the COVID-19 vaccine, with majority of them expressing skepticisms about the vaccine's efficacy. It is possible that many of the people who would not be vaccinated would have an impact on the implementation of a COVID-19 immunisation programme that is meant for all of society. Majority of the respondents were unwilling to pay for the COVID-19 vaccines when made available. An awareness campaign should be focused on promoting the benefits of vaccination at the individual and population levels, as well as on taking preemptive actions to debunk misconceptions about the vaccines before they become further widespread.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Effectiveness of media campaigns on COVID-19 vaccine.
(A) vaccine awareness campaign with the most reach. (B) COVID-19 test by participants. (C) level of COVID-19 vaccine hesitancy among adult Africans.
See this image and copyright information in PMC

References

    1. Hui DS I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al.. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases. 2020. pp. 264–266. doi: 10.1016/j.ijid.2020.01.009 - DOI - PMC - PubMed
    1. WHO. Coronavirus disease 2019 (COVID-19) Situation Report-86. 2020. Available: https://www.who.int/teams/risk-communication/infodemic-management
    1. Zhou P, lou Yang X, Wang XG, Hu B, Zhang L, Zhang W, et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020 579:7798. 2020;579: 270–273. doi: 10.1038/s41586-020-2012-7 - DOI - PMC - PubMed
    1. Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, Yuan S, et al.. Genomic characterisation of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections. 2020;9: 221–236. 10.1080/22221751.2020.1719902 - DOI - PMC - PubMed
    1. Tortorici MA, Veesler D. Structural insights into coronavirus entry. Advances in Virus Research. 2019;105: 93–116. doi: 10.1016/bs.aivir.2019.08.002 - DOI - PMC - PubMed